fig1

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Figure 1. Resistance mechanisms and proposed biomarkers (highlighted in blue). Created in BioRender. Marina, A. (2026) https://BioRender.com/hdkg3fu. ADC: Antibody-drug conjugate; ATP: adenosine triphosphate; BRCA1/2: BReast CAncer gene (BRCA)1/2; PI3K: phosphoinositide 3-kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/